Teva Pharmaceutical Industries Ltd. said it reached a national settlement agreement worth up to $4.25 billion to resolve thousands of lawsuits over its alleged role in the opioid crisis.
The proposed settlement is the latest move by a company seeking to resolve the costly litigation.